← All patents

US20180303812A1

Pharmaceutical composition for use in treating aml and method of treating aml …

University of Texas System

Abstract

The present invention provides a pharmaceutical composition for use in treating acute myeloid leukemia (AML) and a method of treating AML in a patient in need thereof. The present invention also provides a method for predicting the sensitivity to the treatment in the patient using gene expression …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Kenji Nakamaru
Priority date
October 23, 2015
Filing date
October 21, 2016
Publication date
October 25, 2018
Language
en
Metadata fetched
August 29, 2026 00:26